OBJECTIVE: To determine the extent of nuclear pleomorphism in pituitary adenomas and the relationship of these cytologic changes to clinical features, endocrine evaluations and proliferative potential. STUDY DESIGN: The study group consisted of 93 sequential patients with pituitary adenomas in which smear and touch preparations were performed. Nuclear pleomorphism was assessed semiquantitatively and compared to immunohistochemical analyses of pituitary hormones on formalin-fixed paraffin sections, endocrine evaluations, clinical observations and proliferative potential as determined by immunoreactivity to Ki-67 on frozen sections. RESULTS: Varying degrees of nuclear pleomorphism were observed in 66/93 tumors. However, these changes were more pronounced in clinically functioning (growth hormone, prolactin or ACTH), as compared to nonfunctioning, tumors (P < .01). Pleomorphism did not correlate with macroscopic invasiveness. The pituitary adenomas that showed pleomorphism had significantly higher Ki-67 indices than did those without nuclear changes (P < .02). Significantly higher Ki-67 expression was also found in clinically functioning tumors when compared to nonfunctioning tumors (P < .03). CONCLUSION: Significant nuclear pleomorphism is common in functional pituitary adenomas of several types but does not correlate with more aggressive behavior.
OBJECTIVE: To determine the extent of nuclear pleomorphism in pituitary adenomas and the relationship of these cytologic changes to clinical features, endocrine evaluations and proliferative potential. STUDY DESIGN: The study group consisted of 93 sequential patients with pituitary adenomas in which smear and touch preparations were performed. Nuclear pleomorphism was assessed semiquantitatively and compared to immunohistochemical analyses of pituitary hormones on formalin-fixed paraffin sections, endocrine evaluations, clinical observations and proliferative potential as determined by immunoreactivity to Ki-67 on frozen sections. RESULTS: Varying degrees of nuclear pleomorphism were observed in 66/93 tumors. However, these changes were more pronounced in clinically functioning (growth hormone, prolactin or ACTH), as compared to nonfunctioning, tumors (P < .01). Pleomorphism did not correlate with macroscopic invasiveness. The pituitary adenomas that showed pleomorphism had significantly higher Ki-67 indices than did those without nuclear changes (P < .02). Significantly higher Ki-67 expression was also found in clinically functioning tumors when compared to nonfunctioning tumors (P < .03). CONCLUSION: Significant nuclear pleomorphism is common in functional pituitary adenomas of several types but does not correlate with more aggressive behavior.
Authors: Jay Jagannathan; Adam S Kanter; Claire Olson; Jonathan H Sherman; Edward R Laws; Jason P Sheehan Journal: J Neurooncol Date: 2008-06-21 Impact factor: 4.130
Authors: Alexander Micko; Fabian Placzek; Roger Fonollà; Michael Winklehner; Ryan Sentosa; Arno Krause; Greisa Vila; Romana Höftberger; Marco Andreana; Wolfgang Drexler; Rainer A Leitgeb; Angelika Unterhuber; Stefan Wolfsberger Journal: Front Endocrinol (Lausanne) Date: 2021-10-18 Impact factor: 5.555